Your browser doesn't support javascript.
loading
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience.
Tefferi, Ayalew; Gangat, Naseema; Shah, Mithun; Alkhateeb, Hassan; Patnaik, Mrinal S; Al-Kali, Aref; Elliott, Michelle A; Hogan, William J; Litzow, Mark R; Hook, Christopher C; Mangaonkar, Abhishek; Viswanatha, David; Chen, Dong; Pardanani, Animesh; Ketterling, Rhett P; Begna, Kebede H.
Affiliation
  • Tefferi A; Department of Internal Medicine and Division of Hematology.
  • Gangat N; Department of Internal Medicine and Division of Hematology.
  • Shah M; Department of Internal Medicine and Division of Hematology.
  • Alkhateeb H; Department of Internal Medicine and Division of Hematology.
  • Patnaik MS; Department of Internal Medicine and Division of Hematology.
  • Al-Kali A; Department of Internal Medicine and Division of Hematology.
  • Elliott MA; Department of Internal Medicine and Division of Hematology.
  • Hogan WJ; Department of Internal Medicine and Division of Hematology.
  • Litzow MR; Department of Internal Medicine and Division of Hematology.
  • Hook CC; Department of Internal Medicine and Division of Hematology.
  • Mangaonkar A; Department of Internal Medicine and Division of Hematology.
  • Viswanatha D; Division of Hematopathology.
  • Chen D; Division of Hematopathology.
  • Pardanani A; Department of Internal Medicine and Division of Hematology.
  • Ketterling RP; Division of Cytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN.
  • Begna KH; Department of Internal Medicine and Division of Hematology. begna.kebede@mayo.edu.
Haematologica ; 107(10): 2474-2479, 2022 10 01.
Article in En | MEDLINE | ID: mdl-35734931
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Idarubicin / Leukemia, Myeloid, Acute Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Haematologica Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Idarubicin / Leukemia, Myeloid, Acute Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Haematologica Year: 2022 Type: Article